Send to:

Choose Destination
See comment in PubMed Commons below
Methods Mol Biol. 2007;377:131-8.

Gene expression profiles and prognostic markers for primary breast cancer.

Author information

  • 1Veridex LLC, Johnson and Johnson Company, San Diego, CA, USA.


Genome-wide measures of gene expression have been used to classify breast tumors into clinically relevant subtypes, as well as provide a better means of risk assessment on an individual basis for lymph node-negative (LNN) breast cancer patients. We have applied Affymetrix GeneChips of 22,000 transcripts to analyze total RNA of frozen tumor samples from 286 LNN breast cancer patients in order to identify a gene signature for identification of patients at high risk for distant recurrence.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk